Pei Liu

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0009-0008-9488-8747

发表论文 26 篇 · 总被引 1009 次 · h-index 11

代表论文

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2013 · The Lancet · 被引 392)
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial (2015 · The Lancet · 被引 187)
Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial (2016 · The Lancet Global Health · 被引 102)
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial (2013 · The Lancet · 被引 88)
Open-label phase I clinical trial of Ad5-EBOV in Africans in China (2017 · Human Vaccines & Immunotherapeutics · 被引 38)
Human health risk assessment of cadmium via dietary intake by children in Jiangsu Province, China (2016 · Environmental Geochemistry and Health · 被引 32)